Synthetic data only. Never enter patient information; nothing is sent or stored. For clinicians. Not FDA cleared.

CPE-004 · synthetic case IRON-FX-05

Rheumatoid arthritis: ferritin 85, TSAT 12

Hb 10.4 with a ferritin that looks normal and a CRP of 18.

Synthetic · no real patientAuthored by Biod · reviewed by Dr. AmaralIron engine v1.0.0

Purpose: Hb 10.4 with a ferritin that looks normal and a CRP of 18.

Inputs the engine received

Iron studies

Ferritin
85 ng/mL
Serum iron
38 µg/dL
TIBC
316 µg/dL
hs-CRP
18 mg/L

CBC

Hemoglobin
10.4 g/dL
MCV
82 fL

Patient

Age
58 years
Sex
Female
Postmenopausal
Yes

Conditions and risk groups

Active inflammation or infection
Yes

What the engine reports

Detected clinical pattern

Possible Inflammation-Associated Iron Restriction

Low transferrin saturation with ferritin raised by inflammation. Anemia of inflammation and combined deficiency cannot be separated from these values.

  • Validity: Ferritin read with inflammation
  • Anemia: Anemia (Hb 10.4 g/dL)

Why this pattern was identified

  • Possible inflammation-associated iron restriction. Ferritin 85 ng/mL with transferrin saturation 12% during inflammation cannot separate anemia of inflammation from combined deficiency.

Calculations

Transferrin saturation
12%

Serum iron ÷ TIBC × 100.

Differentials, pitfalls and contradicting signals

  • Ferritin is an acute-phase reactant: a normal or high value does not exclude iron deficiency while inflammation is present.
  • Anemia of inflammation with or without coexisting absolute iron deficiency: these values cannot tell them apart.
Evidence and rule trace · 4 rules

ID-CALC-01Derived values

Inputs: iron 38, TIBC 316

Derived values calculated.

ID-VAL-01Inflammation changes how ferritin is read

Inputs: inflammation documented · hs-CRP 18 mg/L

Ferritin cutoffs shift; transferrin saturation weighed alongside.

ID-ST-05Inflammation-associated iron restriction possible

Inputs: ferritin 85 ng/mL · TSAT 12% · inflammation

Functional iron restriction possible (anemia of inflammation, with or without absolute deficiency).

ID-AN-01Anemia present by WHO thresholds

Inputs: hemoglobin 10.4 g/dL (<12)

Anemia by WHO hemoglobin thresholds.

Evidence

  • EV-WHO-FERR-2020 · World Health Organization. WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations. Geneva: WHO; 2020.
  • EV-WHO-HB-2011 · World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Geneva: WHO; 2011.
  • EV-CAMASCHELLA-2015 · Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015;372(19):1832-1843.
  • EV-AHA-HF-2022 · Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Circulation. 2022;145(18):e895-e1032.
  • EV-MENTZER-1973 · Mentzer WC Jr. Differentiation of iron deficiency from thalassaemia trait. Lancet. 1973;1(7808):882.

Physician adjudication required. Clinical decision support for physician review. This output identifies laboratory patterns and safety considerations. It does not diagnose, find a cause, or select an iron product, dose or route. Physician adjudication is required.

Change the values

The same engine, starting from this case. Change any value and watch the pattern and the rule trace react.

Stage of iron deficiency

  1. ○ 1 · Stores depleted

    Low ferritin, normal CBC

  2. ○ 2 · Iron-deficient erythropoiesis

    Low TSAT or reticulocyte Hb, Hb still normal

  3. ○ 3 · Anemia

    Hemoglobin below the WHO threshold

No stage is assigned for the values entered.

Against typical reference intervals

Ferritin85 ng/mL · within reference
ref 30300
MCV82 fL · within reference
ref 80100
Iron studiesDrag or type
  • <15 depleted
  • 15–29 low
  • 30–44 borderline
  • 45–299
  • 300–999 high
  • >1000 very high

Calculated from iron ÷ TIBC when both are entered.

Above 5 mg/L the engine reads ferritin as inflammation-affected.

CBC
  • <7 severe
  • 7–11.9 anemia range
  • 12–12.9 (men <13)
  • ≥13
Patient
Sex
Symptoms and findings
Conditions and risk groups
Work-up and treatment context

Live result · computed in your browser

Detected clinical pattern

Possible Inflammation-Associated Iron Restriction

Low transferrin saturation with ferritin raised by inflammation. Anemia of inflammation and combined deficiency cannot be separated from these values.

  • Validity: Ferritin read with inflammation
  • Anemia: Anemia (Hb 10.4 g/dL)

Why this pattern was identified

  • Possible inflammation-associated iron restriction. Ferritin 85 ng/mL with transferrin saturation 12% during inflammation cannot separate anemia of inflammation from combined deficiency.

Calculations

Transferrin saturation
12%

Serum iron ÷ TIBC × 100.

Differentials, pitfalls and contradicting signals

  • Ferritin is an acute-phase reactant: a normal or high value does not exclude iron deficiency while inflammation is present.
  • Anemia of inflammation with or without coexisting absolute iron deficiency: these values cannot tell them apart.
Evidence and rule trace · 4 rules

ID-CALC-01Derived values

Inputs: iron 38, TIBC 316

Derived values calculated.

ID-VAL-01Inflammation changes how ferritin is read

Inputs: inflammation documented · hs-CRP 18 mg/L

Ferritin cutoffs shift; transferrin saturation weighed alongside.

ID-ST-05Inflammation-associated iron restriction possible

Inputs: ferritin 85 ng/mL · TSAT 12% · inflammation

Functional iron restriction possible (anemia of inflammation, with or without absolute deficiency).

ID-AN-01Anemia present by WHO thresholds

Inputs: hemoglobin 10.4 g/dL (<12)

Anemia by WHO hemoglobin thresholds.

Evidence

  • EV-WHO-FERR-2020 · World Health Organization. WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations. Geneva: WHO; 2020.
  • EV-WHO-HB-2011 · World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Geneva: WHO; 2011.
  • EV-CAMASCHELLA-2015 · Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015;372(19):1832-1843.
  • EV-AHA-HF-2022 · Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Circulation. 2022;145(18):e895-e1032.
  • EV-MENTZER-1973 · Mentzer WC Jr. Differentiation of iron deficiency from thalassaemia trait. Lancet. 1973;1(7808):882.

Physician adjudication required. Clinical decision support for physician review. This output identifies laboratory patterns and safety considerations. It does not diagnose, find a cause, or select an iron product, dose or route. Physician adjudication is required.

More iron cases

All iron cases

The Clinical Intelligence Layer — transforming fragmented clinical information into structured intelligence for clinician review and action.

Contact Biod